EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy)

Michael H Carstens iD, Nelson García, Sreedhar Mandayam, Biruh Workeneh, Indiana Pastora, Carlos Calderón, Kenneth A Bertram, Diego Correa

Stem Cells Translational Medicine · 2023

DOI: 10.1093/stcltm/szac080 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Stem Cells Translational Medicine, 2023. Verfasst von Michael H Carstens und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua. Hauptthemen laut MEDLINE: Chronic Kidney Diseases of Uncertain Etiology, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GID Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease of unknown cause (CKDu), also known as Mesoamerican nephropathy, typically presents as an ischemic nephropathy with chronic tubulointerstitial fibrosis in normotensive patients, rapidly progressing to kidney failure. In this first-in-human, open-label, safety study, we followed 18 patients with CKDu (stages 3-5) for 36 months after receiving a single infusion of angiogenic/anti-fibrotic autologous adipose-derived stromal vascular fraction (SVF) cells into their kidneys bilaterally via renal artery catheterization. SVF therapy was safe and well tolerated. There were no SVF-related serious adverse events and no procedural complications. Color Doppler evaluation at 2 months demonstrated increased perfusion to the interlobar and/or arcuate artery levels in each kidney evaluated (36/36) with a reduction in resistance index at the hilar artery (35/36) kidneys. Beyond 12 months, patients with initial eGFR <30 mL/minute/1.73 m2 deteriorated, whereas those ≥30 mL/minute/1.73 m2 further sustained their renal function, suggesting a possible renal protective effect in that group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic Kidney Diseases of Uncertain EtiologyRenal Insufficiency, ChronicHumansAdipose TissueCell- and Tissue-Based TherapyFibrosisKidneyStromal CellsStromal Vascular Fraction

Stichwörter der Autor:innen

Mesoamerican nephropathycell-based therapychronic kidney disease of unknown cause (CKDu)neovascularizationsafetystromal vascular fraction (SVF)

Autor:innen und Institutionen

  • Department of Surgery, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua.
  • Hospital Vivian Pellas, Managua, Nicaragua.
  • Wake Forest University Institute for Regenerative Medicine, Winston-Salem, NC, USA.
  • Department of Medicine, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua.
  • Nephrology section, Ministerio de Salud, República de Nicaragua.
  • Department of Nephrology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

ORCID-Profile: Michael H Carstens

Förderung

  • GID Group

Zitieren

APA

Carstens, M. H., García, N., Mandayam, S., Workeneh, B., Pastora, I., Calderón, C., Bertram, K. A., & Correa, D. (2023). Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy). Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szac080

Vancouver

Carstens MH, García N, Mandayam S, Workeneh B, Pastora I, Calderón C, et al. Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy). Stem Cells Translational Medicine. 2023. doi:10.1093/stcltm/szac080

BibTeX
@article{Carstens2023,
  author = {Carstens, Michael H and García, Nelson and Mandayam, Sreedhar and Workeneh, Biruh and Pastora, Indiana and Calderón, Carlos and Bertram, Kenneth A and Correa, Diego},
  title = {Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy)},
  journal = {Stem Cells Translational Medicine},
  year = {2023},
  doi = {10.1093/stcltm/szac080}
}
Kostenlos starten →